Alexion Pharmaceuticals Inc (NASDAQ:ALXN) - Share price - Overview

Stock Report

Alexion Pharmaceuticals Inc ALXN

Last Price
$120.47

Day Change
-2.24|-1.83%

As of 16/02/2018
18:24:41 EST | USD
Minimum 15 Minutes Delay.

Last Close122.71
Day Range119.24 - 123.17
Mkt Cap26.71Bil
52-Wk Range96.18 - 149.34
Yield %-
ISINUS0153511094
Volume3,898,513
P/E61.15
P/S7.65
P/CF24.34

Share Price

Financials
201520162017
More ...
Income Statement
Revenue2,604.053,084.003,551.10
Operating Income536.67667.00627.40
Net Income144.39399.00443.30
Basic EPS0.681.781.98
Avg. Diluted Shares Outstanding216227225
Balance Sheet
Current Assets2,425.352,578.002,953.90
Non Current Assets10,707.8810,675.0010,629.40
Total Assets13,133.2313,253.0013,583.30
Current Liabilities718.25823.00952.50
Total Liabilities4,874.614,559.004,690.20
Total Equity8,258.628,694.008,893.10
Cash Flow
Operating Cash Flow675.201,086.001,115.60
Capital Expenditure-286.34-333.00-357.30
Free Cash Flow388.86753.00758.30

In millions, except "Basic EPS". Currency is USD.

Company Profile

Alexion Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

2,525
Key Stats
More ...
Price/Earning TTM61.97
Price/Book3.06
Price/Sales TTM8.02
Rev Growth (3 year avg)16.71
EPS Growth (3 year avg)-
Operating Margin % TTM17.67
Net Margin % TTM12.48
ROE TTM5.04
Debt/Equity0.34
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.